β,β-디메틸아크릴알칸닌에 의한 FGFR1 표적화가 세포 및 이종이식 모델에서 대장암의 증식을 억제하다

Zhao 등(목,)이 이 문제를 연구했다.

www.synapsesocial.com/papers/68e6d978b6db643587655a82 — DOI: https://doi.org/10.1016/j.phymed.2024.155612

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Patient-derived tumour xenografts as models for oncology drug development· 2012 · 1,294 citations
2. Cancer statistics, 2023· 2023 · 16,495 citations
3. Shikonin inhibits triple-negative breast cancer-cell metastasis by reversing the epithelial-to-mesenchymal transition via glycogen synthase kinase 3β-regulated suppression of β-catenin signaling· 2019 · 64 citations
4. Fibroblast Growth Factor Receptor 1 as a Putative Therapy Target in Colorectal Cancer· 2013 · 30 citations
5. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries· 2018 · 87,560 citations